Related Experiment Video
Updated: Jan 3, 2026
07:54
Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
20.4K
Benzodiazepines use in Morocco: A nation wide consumption database study between 2004 and 2017
Zidane Qriouet1, Abdelmajid Belaiche2, Zineb Qmichou3
1Centre de biotechnologie médicale, Moroccan foundation for Science, Innovation & Research (MAScIR), Rabat, Morocco; Laboratoire de Pharmacologie et Toxicologie, Faculté de Médecine et de pharmacie, Université Mohammed V-Souissi, Rabat, Morocco.
Asian Journal of Psychiatry
|November 24, 2019
Summary
This study reveals benzodiazepine (BZD) consumption trends in Morocco from 2004-2017. Bromazepam was most used until 2016, with Alprazolam leading in 2017, highlighting evolving BZD prescription patterns.
Area of Science:
- Pharmacology
- Public Health
- Drug Utilization Studies
Background:
- Limited data exists on benzodiazepine (BZD) consumption rates in Morocco.
- Understanding prescription patterns is crucial for public health initiatives and drug safety.
Purpose of the Study:
- To describe the prescription rate and consumption trends of benzodiazepines and their agonists in Morocco.
- To provide baseline data for analytical toxicology and health organizations.
Main Methods:
- Retrospective descriptive analysis of BZD and agonist sales data.
- Utilized the IQVIA database for the period 2004-2017.
- Data expressed as daily defined doses per 1000 inhabitants per day (DDD/1000 inh/day).
Main Results:
- Bromazepam was the most consumed BZD from 2004-2016.
- In 2017, Alprazolam became the most consumed, followed by Bromazepam.
- Total annual consumption of BZDs and agonists showed an increasing trend from 2004 to 2014, then a slight decrease.
Conclusions:
- This is the first study detailing BZD and agonist consumption in Morocco.
- Findings provide essential data for developing targeted BZD detection and quantification methods for the Moroccan population.
- Highlights the need for continued monitoring of psychotropic drug utilization.
Related Concept Videos
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
693
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
693
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone
2.2K
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
2.2K
01:14CNS Depressants: Barbiturates and Benzodiazepines
1.1K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.1K
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
457
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
457
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
158
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
158
01:23Sedatives and Hypnotics: Overview
1.3K
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
1.3K